Sisay Sitotaw Anberbr

Mr. Sisay Sitotaw Anberbr


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 May 2026 in BMJ Open
Verified
Journal Article
Open access
PDF file
ABAlemneh Ayu Biyazin
Alemneh Ayu Biyazin
GMGashaw Binega Mekonnen
Gashaw Binega Mekonnen
SASisay Sitotaw Anberbr
Sisay Sitotaw Anberbr
GYGetachew Yitayew
Getachew Yitayew
TZTigabu Eskeziya Zerihun
Tigabu Eskeziya Zerihun
RARahel Belete Abebe
Rahel Belete Abebe
Objectives The study aimed to determine treatment outcome and factors affecting treatment outcomes among hospitalised patients with skin and soft tissue infections (SSTIs) at the University of Gondar Comprehensive Specialised Hospital (UOGCSH) in Ethiopia. Design An institution-based prospective observational study. Setting UOGCSH, Northwest Ethiopia. Participants 423 patients from all age groups with clinically diagnosed SSTIs from 25 June to 25 December 2023 at the UOGCSH were included. Outcome measures Primary treatment outcomes were early apparent clinical response within 48–72 hours and treatment failure after 72 hours of optimal antibiotic therapy. Secondary treatment outcomes included hospital length of stay (HLOS) and in-hospital mortality. Multiple linear regression assessed factors influencing the HLOS, and multivariable logistic regression identified predictors of treatment failure. Results The average HLOS was 13.46±3.01 days. Of the patients, 39.3% had an early clinical response within 48–72 hours, whereas 34.4% had treatment failure. At 0.7%, the in-hospital death rate was modest. Living in a rural area (adjusted OR (AOR) 5.54, 95% CI 2.67 to 11.37), having concurrent illnesses (AOR 2.11, 95% CI 1.10 to 4.07) and starting antibiotics later than 12 hours (AOR 0.08, 95% CI 0.04 to 0.17) were significantly associated with treatment failure. Concomitant disorders and complex comorbidities were also associated with longer HLOS, whereas higher socioeconomic level, oral step-down therapy, early antibiotic initiation and early clinical response were linked to better results and shorter hospital stays. Conclusion Timely antibiotic initiation, efficient source control, patient comorbidities and socio-economic considerations affect the treatment course for SSTIs. Prolonged treatment and the frequent use of ‘watch’ and ‘reserve’ antibiotics underscore the need for improved antimicrobial stewardship. In this situation, optimising clinical results and minimising HLOS requires prompt clinical evaluation and customised antibiotic therapy. However, the single-centre design and potential residual confounding may introduce bias.

9 October 2025 in Therapeutic Advances in Chronic Disease
Verified
Journal Article
Open access
TMTilaye Arega Moges
Tilaye Arega Moges
SDSamuel Berihun Dagnew
Samuel Berihun Dagnew
SASisay Sitotaw Anberbr
Sisay Sitotaw Anberbr
BBBayih Endalew Bitew
Bayih Endalew Bitew
MKMekdes Kiflu
Mekdes Kiflu
woretaw  sisayworetaw sisay
woretaw sisay
Background: Antilipidemic therapy adherence to medication among patients with dyslipidemia and type 2 diabetes mellitus (T2DM) remains suboptimal, particularly in developing countries. Poor adherence to lipid-lowering therapy is associated with a significantly higher risk of major adverse cardiovascular outcomes in this population than in the general population. Objectives: This study aimed to assess the level of non-adherence to antilipidemic medications and associated socio-demographic and clinical factors among patients attending comprehensive specialized hospitals (CSHs) in Northwest Ethiopia. Design: This multicenter, prospective, cross-sectional study was conducted at CSHs in Northwest Ethiopia from November 10, 2023 to January 30, 2024. Methods: Data were entered using EpiData version 4.6.0.0 and analyzed using STATA version 17.0. The Adherence in Chronic Diseases Scale was used to assess medication adherence. Multinomial logistic regression analysis was used to identify factors associated with non-adherence, and model fitness was checked before interpretation. Results: The study included 398 patients, yielding a response rate of 98.76%. Of these patients, 290 (72.9%) were classified as non-adherent to their antilipidemic medications. Factors significantly associated with medium and low medication adherence included female sex (adjusted odds ratio (AOR) for medium: 2.94, 95% confidence interval (CI): 1.61–5.38; AOR for low: 3.09, 95% CI: 1.66–5.76), unmarried status (AOR for medium: 2.83, 95% CI: 1.52–5.27; AOR for low: 2.72, 95% CI: 1.43–5.17), current smoking (AOR for medium: 3.25, 95% CI: 1.20–8.82; AOR for low: 6.54, 95% CI: 2.46–17.36), presence of comorbidities (AOR for medium: 3.01, 95% CI: 1.65–5.49; AOR for low: 2.41, 95% CI: 1.29–4.47), and polypharmacy (⩾5 medications) (AOR for medium: 3.00, 95% CI: 1.60–5.63; AOR for low: 4.87, 95% CI: 2.56–9.24). Conclusion: This study revealed a high prevalence of medication non-adherence among patients with T2DM with dyslipidemia in Northwest Ethiopia. Non-adherence was significantly associated with female gender, unmarried status, smoking, comorbid conditions, and polypharmacy. These findings emphasize the need for targeted strategies to improve adherence in high-risk populations to enhance lipid control and lower the likelihood of cardiovascular complications.

5 March 2026 in Therapeutic Advances in Infectious Disease
Verified
Journal Article
Open access
woretaw  sisayworetaw sisay
woretaw sisay
MAMuluken Adela Alemu
Muluken Adela Alemu
TMTilaye Arega Moges
Tilaye Arega Moges
SASisay Sitotaw Anberbr
Sisay Sitotaw Anberbr
DMDesalegn Addis Mussie
Desalegn Addis Mussie
SDSamuel Berihun Dagnew
Samuel Berihun Dagnew
Background: Despite prophylactic pharmacotherapy being ranked as the best intervention yet, poor treatment adherence tempers tuberculosis preventive therapy (TPT) efficacy. Objectives: This study aimed to investigate TPT non-adherence among household contacts and its determinants following the rollout of the 3HP regimen in northwest Ethiopia. Design: A facility-based multicenter retrospective study was conducted in selected hospitals of northwest Ethiopia from October 17 to February 21, 2024. Methods: Target populations were TPT-eligible household contacts (⩽15 years old) based on the national tuberculosis treatment guideline. Univariate and multivariate binary logistic regression model was fitted to identify potential predictors. p -Value < 0.05 was employed to adjudicate the significance level. Results: Among 494 household contacts (HHCs) enrolled in this study, 27.94% were non-adherent. Age (5–10 years: adjusted odds ratio (AOR) (95% CI): 1.92 (1.05–3.19); 10–15 years: AOR (95% CI): 2.04 (1.01–4.12)), parental status (AOR (95% CI): 1.87 (1.02–5.24)), comorbidity (AOR (95% CI): 2.92 (1.08–5.69)), poor nutritional status (AOR (95% CI): 1.30 (1.06–2.43)), adverse drug reactions (AOR (95% CI): 4.01 (1.03–8.20)), adherence support (AOR (95% CI): 1.56 (1.08–6.69)) and TPT regimen type (AOR (95% CI): 4.23 (1.85–6.53)) predicts non-adherence. Conclusion: Altogether, this study revealed a high level of non-adherence among HHCs in northwest Ethiopia, falling short of the national 2025/26 TPT targets. TPT should be accompanied by firm counseling and routine supervision to improve adherence.

27 June 2025 in Heart Rhythm O2
Verified
Journal Article
Open access
SASisay Sitotaw Anberbr
Sisay Sitotaw Anberbr
OAOusman Abubeker Abdela
Ousman Abubeker Abdela
ABAlemneh Ayu Biyazin
Alemneh Ayu Biyazin
GGGebremariam Wulie Geremew
Gebremariam Wulie Geremew
AGAdane Desta Getahun
Adane Desta Getahun
MTMasho Tigabe Tekle
Masho Tigabe Tekle
Adhering well to guideline-directed medical therapy (GDMT) is essential for improving treatment outcomes in patients with heart failure (HF) with reduced ejection fraction (HFrEF). Despite its significance, studies on the status of GDMT adherence in patients with HF in Ethiopia are scarce. This study aimed to assess physicians' adherence to GDMT and the associated factors in patients with HFrEF. A retrospective follow-up study was conducted from September 1, 2018, to July 31, 2023. Quality of Adherence to Guideline Recommendations for Lifesaving Treatment in Heart Failure Survey scores were used to assess physicians' adherence to GDMT. SPSS version 27.0 was used for analysis, and multinomial logistic regression analysis was performed. The Quality of Adherence to Guideline Recommendations for Lifesaving Treatment in Heart Failure Survey scores showed that the physicians' adherence to GDMT was good in 40% (95% confidence interval [CI] 35.30-44.90), moderate in 33.8% (95% CI 29.3-38.6), and poor in 26.2% of the study participants (95% CI 22-30.7). Age of ≥65 years (adjusted odds ratio [AOR] 0.14, 95% CI 0.07-0.29); causes of HF such as ischemic heart disease (AOR 16, 95% CI 6.75-37.90), valvular heart disease (AOR 5.3, 95% CI 2.58-10.92), dilated cardiomyopathy (AOR 8.24, 95% CI 3.97-17.09), and hypertension (AOR 6.62, 95% CI 2.98-14.69); and duration of HFrEF of ≥3 years (AOR 2.59, 95% CI 1.32-5.08) were factors significantly associated with good physicians' adherence to GDMT. The use of all indicated medications as per the guideline recommendation for HFrEF was low, and most patients received suboptimal doses of GDMT. Particularly, the beta-blocker dose was very suboptimal. Encouraging healthcare provider training, access to separate cardiac clinics and cardiologists, following guidelines, timely patient appointments, and medication availability are recommended for better clinical outcomes.

30 September 2025 in BMJ Open
Verified
Journal Article
Open access
PDF file
AGAdane Desta Getahun
Adane Desta Getahun
EAEmneteab Mesfin Ayele
Emneteab Mesfin Ayele
TTTilahun Degu Tsega
Tilahun Degu Tsega
SASisay Sitotaw Anberbr
Sisay Sitotaw Anberbr
GGGebremariam Wulie Geremew
Gebremariam Wulie Geremew
GMGizework Alemnew Mekonnen
Gizework Alemnew Mekonnen
Objective To assess the time to first optimal glycaemic control and its predictors among adult patients with type 1 and type 2 diabetes at the University of Gondar Comprehensive Specialized Hospital in Ethiopia. Design A retrospective cohort study. Setting University of Gondar Comprehensive Specialized Hospital, northwest, Ethiopia. Participants We recruited 423 adult diabetic patients who were diagnosed between 1 January 2018 and 30 December 2022 at the University of Gondar Comprehensive Specialized Hospital. Outcome measures The primary outcome was the time from diagnosis to the achievement of the first optimal glycaemic control, measured in months. A Cox proportional hazards regression model was fitted to identify predictors of time to first optimal glycaemic control. Data were collected with KoboToolbox from patient medical charts and exported to Stata V.17. The log-rank test was used to determine the survival difference between subgroups of participants. Results Median time to first optimal glycaemic control was 10.6 months. Among 423 adult diabetic patients, 301 (71.16%) achieved the first optimal glycaemic control during the study period. Age category (middle age (adjusted HR (AHR)=0.56, 95% CI 0.41 to 0.76), older age (AHR=0.52, 95% CI 0.33 to 0.82)), comorbidity (AHR=0.52, 95% CI 0.35 to 0.76), therapeutic inertia (AHR=0.20, 95% CI 0.13 to 0.30) and medication non-compliance (AHR=0.49, 95% CI 0.27 to 0.89) were significant predictors of time to optimal glycaemic control. Conclusion The median time to first optimal glycaemic control was prolonged. Diabetic care should focus on controlling the identified predictors to achieve optimal glycaemic control early after diagnosis.

12 February 2026 in BMJ Open
Verified
Journal Article
Open access
GYGetachew Yitayew
Getachew Yitayew
FDFisseha Nigussie Dagnew
Fisseha Nigussie Dagnew
SWSamuel Agegnew Wondm
Samuel Agegnew Wondm
SASisay Sitotaw Anberbr
Sisay Sitotaw Anberbr
FTFasil Bayafers Tamene
Fasil Bayafers Tamene
TMTilaye Arega Moges
Tilaye Arega Moges
Objectives: To assess health-related quality of life (HRQoL), treatment satisfaction and associated factors among older adults with acute heart failure in Northwest Ethiopia. Design: Prospective, multicentre observational study. Setting: Three tertiary hospitals in Northwest Ethiopia provide secondary and tertiary care services. Participants: A total of 422 patients aged ≥60 years with a confirmed diagnosis of acute heart failure were consecutively enrolled between December 2024 and April 2025. Patients with unstable psychiatric conditions or advanced kidney disease were excluded. Outcome measures: HRQoL was assessed using the WHO Quality of Life – Brief Version questionnaire, and treatment satisfaction was measured using the Treatment Satisfaction Questionnaire for Medication (TSQM). Multiple linear regression identified factors associated with HRQoL and treatment satisfaction. Results: 95% of participants reported moderate HRQoL, and 3% reported poor HRQoL. Weight loss was positively associated with HRQoL (β=1.52; 95% CI 0.04 to 3.07; p=0.021), whereas asthma was negatively associated with HRQoL (β = –3.28; 95% CI 6.94 to 0.37; p=0.001). Regarding treatment satisfaction, 65% of patients were moderately satisfied, with notable concerns regarding medication safety and overall experience. Rural residents reported lower satisfaction than urban residents (β = –0.20; 95% CI 0.34 to 0.05; p=0.007). Patients with New York Heart Association (NYHA) class III had higher satisfaction (β=0.25; 95% CI 0.05 to 0.45; p=0.016). Effective hypertension management was linked to increased satisfaction (β=0.20; 95% CI 0.02 to 0.37; p=0.026), whereas coronary heart disease was associated with lower satisfaction (β = –0.40; 95% CI 0.64 to 0.88; p=0.012). Conclusions: Among older adults with heart failure in Northwest Ethiopia, 98% reported moderate to low HRQoL. Asthma and polypharmacy negatively affected HRQoL, whereas weight loss was positively associated with HRQoL. An NYHA class III status and well-managed hypertension improved treatment satisfaction, whereas rural residency and coronary heart disease were associated with lower satisfaction. These findings underscore the need for targeted interventions to enhance outcomes and QoL in this vulnerable population.